Conivaptan
Generic name: Conivaptan
Brand names: Vaprisol
Dosage form: intravenous solution (20 mg/100 mL-D5%)
Drug class:
Vasopressin antagonists
Usage of Conivaptan
Conivaptan reduces the level of a hormone that regulates the balance of water and salt (sodium) in the body. High levels of this hormone can cause an imbalance that results in low sodium levels and fluid retention.
Conivaptan is used to treat hyponatremia (low sodium levels). Conivaptan improves urine flow without causing the body to lose too much sodium as you urinate.
Conivaptan may also be used for purposes not listed in this medication guide.
Conivaptan side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Tell your caregivers at once if you have:
Common side effects of conivaptan may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Conivaptan
You should not receive conivaptan if you are allergic to corn products, or if you are unable to urinate.
Some medicines can cause unwanted or dangerous effects when used with conivaptan. Your doctor may need to change your treatment plan if you use any of the following drugs:
To make sure conivaptan is safe for you, tell your doctor if you have:
It is not known whether conivaptan will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
This medicine may affect fertility (ability to have children) in women.
It is not known whether conivaptan passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are receiving conivaptan.
Relate drugs
How to use Conivaptan
Usual Adult Dose for Hyponatremia:
Initial dose: Loading dose of 20 mg IV once over 30 minutes; followed by 20 mg continuous IV infusion over 24 hours-Following initial day of treatment, administer 20 mg continuous IV infusion over 24 hours for an additional 1 to 3 days; may titrate to a maximum of 40 mg continuous IV infusion over 24 hours if serum sodium is not rising at the desired rateComments:-The total duration of infusion (after the loading dose) should not exceed 4 days.-Frequently monitor serum sodium and volume status during administration.Use: To raise serum sodium in hospitalized patients with euvolemic or hypervolemic hyponatremia
Usual Adult Dose for Hyponatremia, euvolemic:
Initial dose: Loading dose of 20 mg IV once over 30 minutes; followed by 20 mg continuous IV infusion over 24 hours-Following initial day of treatment, administer 20 mg continuous IV infusion over 24 hours for an additional 1 to 3 days; may titrate to a maximum of 40 mg continuous IV infusion over 24 hours if serum sodium is not rising at the desired rateComments:-The total duration of infusion (after the loading dose) should not exceed 4 days.-Frequently monitor serum sodium and volume status during administration.Use: To raise serum sodium in hospitalized patients with euvolemic or hypervolemic hyponatremia
Warnings
You should not receive conivaptan if you are allergic to corn products, or if you are unable to urinate.
Serious drug interactions can occur when certain medicines are used together. Tell your doctor about all your current medicines and any you start or stop using.
What other drugs will affect Conivaptan
Many drugs can interact with conivaptan, and some drugs should not be used together. You may need to wait at least 1 week after your last dose of conivaptan before you can begin taking certain other medicines. Ask your doctor about your specific treatment plan.
Not all possible interactions are listed in this medication guide. Tell your doctor about all your medications and any you start or stop using during treatment with conivaptan. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Give a list of all your medicines to any healthcare provider who treats you.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions